DIFLUNISAL IN OSTEOARTHROSIS OF THE HIP AND KNEE

被引：5

作者：

ESSIGMAN, WK

CHAMBERLAIN, MA

WRIGHT, V

机构：

[1] GEN INFIRM,SCH MED,RHEUMAT RES UNIT,36 CLARENDON RD,LEEDS LS2 9PJ,ENGLAND

[2] LISTER HOSP,STEVENAGE,HERTFORDSHIRE,ENGLAND

[3] UNIV LEEDS,LEEDS LS2 9JT,W YORKSHIRE,ENGLAND

来源：

ANNALS OF THE RHEUMATIC DISEASES | 1979年 / 38卷 / 02期

关键词：

D O I：

10.1136/ard.38.2.148

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Diflunisal (750 mg per day) has been compared with acetylsalicyclic acid (ASA) (3000 mg per day) in the treatment of osteoarthrosis of the hip and knee in a double-blind, randomised, multicentre, outpatient study. Thirty-one patients entered the diflunisal group and 29 the ASA group. The response of the 2 groups was comparable, but the incidence of side effects was higher in the ASA group. At the end of the 12-week period more patients in the diflunisal group close to remain in a further, open study.

引用

页码：148 / 151

页数：4

共 9 条

[1]

BARRAU G, 1978, CLIN THERAPEUTICS SA, V1, P43

[2]

DEVROEY P, 1978, CLIN THER, V1, P30

[3]

HONIG WJ, 1978, DIFLUNISAL CLIN PRAC, P105

[4] COMPARATIVE EFFECTS OF ASPIRIN AND DIFLUNISAL ON PROSTAGLANDIN SYNTHETASE FROM HUMAN PLATELETS AND SHEEP SEMINAL-VESICLES [J].

MAJERUS, PW ;

STANFORD, N .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 4 :S15-S18

[5] PHARMACOLOGY AND TOXICOLOGY OF DIFLUNISAL [J].

STONE, CA ;

VANARMAN, CG ;

LOTTI, VJ ;

MINSKER, DH ;

RISLEY, EA ;

BAGDON, WJ ;

BOKELMAN, DL ;

JENSEN, RD ;

MENDLOWSKI, JB ;

TATE, CL ;

PECK, HM ;

ZWICKEY, RE ;

MCKINNEY, SE .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 4 :S19-S29

[6]

TEMPERO KF, 1976, CLIN RES, V24, pA258

[7]

VANWINZUM C, 1977, BRIT J CLIN PHARMACO, V4, pS39

[8]

WES BJ, 1978, CLIN THER, V1, P34

[9]

WRIGHT V, 1976, ANN RHEUM DIS, V35, P174, DOI 10.1136/ard.35.2.174

← 1 →